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Abstract
Background: Stroke recurrence and disability in patients with a minor stroke is one of the most depressing medical
situations. In this study, we aimed to identify which factors were associated with adverse outcomes of a minor
stroke.
Methods: The China National Stroke Registry (CNSR) is a nationwide prospective registry for patients presented to
hospitals with acute cerebrovascular events between September 2007 and August 2008. The 3-month follow-up
was completed in 4669 patients with a minor stroke defined as the initial neurological severity lower than 4 in the
National Institutes of Health Stroke Scale (NIHSS). Multivariate model was used to determine the association
between risk factors and clinical outcomes.
Results: Of 4669 patients with a minor stroke during 3-month follow-up, 459 (9.8 %) patients experienced recurrent
stroke, 679 (14.5 %) had stroke disability and 168 (3.6 %) died. Multivariate model identified hypertension, diabetes
mellitus, atrial fibrillation, coronary heart disease and previous stroke as independent predictors for the recurrent
stroke. Age, diabetes mellitus, atrial fibrillation, previous stroke and time from onset to admission < 24 h were
independent predictors for stroke disability. The independent predictors for the all-caused death were age, atrial
fibrillation, and coronary heart disease.
Conclusions: The short-term risk of poor clinical outcome in Chinese patients with a minor stroke was substantial.
Therefore, patients with a minor stroke should be given expeditious assessment and urgent aggressive intervention.
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Background
Stroke recurrence and dependency in patients with an
initial non-disabling stroke is one of the most depressing
medical situations worldwide. Stroke has been the lead-
ing cause of death and acquired adult disability in China
[1, 2], furthermore, where the incidence rate of ischemic
stroke increased by 8.7 % annually on average from 1984
to 2004 [3]. Increasing evidences have suggested that a
significant minority of patients with an acute non-
disabling stroke become disabled or dead due to recur-
rent strokes or neurological deterioration within first
few hours or days [4–6]. A population-based study
showed that the true risk of recurrent stroke after minor
stroke is up to about 18 % at 3 months [7]. As for
stroke-related disability, it is relatively common among
the patients with mild or rapid improving symptom
who were not treated with the intravenous thromb-
olysis [5, 6, 8, 9].
Considering the variable clinical course in the immedi-
ate aftermath of a minor stroke, it will become more
important to assess risk factors for detecting patients
with a poorer clinical outcome, for whom aggressive
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prevention treatment like dual or triple antiplatelet is ur-
gently needed. At present, majority of studies have been
focusing on the early risk of recurrent stroke after tran-
sient ischemic attack (TIA) and a minor stroke [10–13],
but data about the short-term risk of poor functional
outcome and subsequent stroke assessed in patients with
minor stroke was limited, and even not available in
China. Using China National Stroke Registry (CNSR),
we aimed to identify factors associated with early stroke
recurrence, stroke disability and all-cause death after an
initial minor stroke during a 90-day follow-up period.
Methods
Study population
The present cohort was from the China National Stroke
Registry (CNSR), which is a nationwide prospective
registry for patients presented to hospitals with acute
cerebrovascular events between September 2007 and
August 2008. The detailed design, rationale, and basic
description of the CNSR have been published previously
[14, 15]. We included patients in the current analysis if
they presented with an ischemic stroke diagnosed ac-
cording to World Health Organization criteria [16, 17]
combined with the confirmation of brain computed
tomography or magnetic resonance imaging. The minor
stroke was defined as the initial neurological severity
lower than 4 in the National Institutes of Health Stroke
Scale (NIHSS) [17, 18]. We excluded the patients with-
out follow-up information at 3 months after stroke on-
set. The study was sponsored by the Ministry of Science
and Technology and the Ministry of Health of the
People’s Republic of China and approved by the central
institutional review board at Beijing Tiantan Hospital
and local ethical committees at each participating hos-
pital. Written informed consent for inclusion was signed
by patients or legally authorized representatives.
Data collection
All research coordinators and study investigators were
trained and certified to assess National Institutes of
Health Stroke Scale scores before the beginning of the
study. We collected baseline information including pa-
tient demographics, vascular risk factors, stroke severity
(NIHSS score at admission and 24 h later), stroke
management, diagnosis and discharge status. Vascular
risk factors included hypertension, diabetes mellitus,
dyslipidemia, atrial fibrillation, coronary heart disease,
previous stroke, current or previous smoking and
moderate or heavy alcohol consumption (≥2 standard
alcohol consumption per day) and body mass index
(BMI) at admission. Hypertension was defined as sys-
tolic blood pressure ≥ 140 mmHg or diastolic blood
pressure ≥ 90 mmHg, any use of antihypertensive drug, or
self-reported history of hypertension. Diabetes mellitus
was defined as fasting glucose level ≥ 7.0 mmol/L,
non-fasting glucose concentration ≥ 11.1 mmol/L, any
use of glucose-lowering drugs, or any self-reported
history of diabetes. Dyslipidemia was defined as
serum triglyceride ≥ 1.7 mmol/L, low-density lipopro-
tein cholesterol ≥ 3.6 mmol/L, high-density lipoprotein
cholesterol ≤ 1.0 mmol/L, any use of lipid-lowering
drugs, or any self-reported history of dyslipidemia.
Atrial fibrillation was defined as history of atrial fib-
rillation confirmed by at least one electrocardiogram
or presence of the arrhythmia during hospitalization.
The treatment of atrial fibrillation defined the use of
anticoagulation agents during hospitalization and after
discharge. BMI was calculated by dividing measured
weight in kilograms by the square of measured height
in meters. In addition, neurological deterioration was
considered as the increase of NIHSS ≥ 4 at 24 h after
admission from baseline [19]. Etiologic subtypes of
ischemic stroke were classified by the Stop Stroke
Study Trial of Org 10172 in Acute Stroke Treatment
(SSS-TOAST) classification criteria [20].
Outcome assessment
The follow up was done by telephone interview. Trained
research personnel making the phone calls were blinded
to patients’ baseline clinical status. Patients were asked
the standardized follow-up questions at 3 months after
stroke onset. Outcomes data collected included stroke re-
currence, stroke disability and all-cause death. Recurrent
cerebrovascular events included ischemic stroke, intracra-
nial hemorrhage and subarachnoid hemorrhage. Cases of
recurrent strokes were cross-checked with the treating
hospitals to ensure the accuracy of diagnosis. In case of a
suspected stroke recurrence without hospitalization, the
case was adjudicated by the trial executive committee.
Stroke disability was defined as modified Rankin Scale
(mRS) of 3–6 at 3 months after stroke onset. All-cause
mortality was defined as death from any cause which was
confirmed by either a death certificate from the local citi-
zen registry or the record of the treating hospital. When
no official documentation was available, case fatality was
decided if death was reported on two consecutive follow-
up periods by different proxies.
Statistical analysis
Continuous variables are expressed as means with stand-
ard deviation (SD) or median with interquartile range
(IQR), as appropriate. Categorical data are presented as
proportions. The differences in baseline demographic
and clinical features between patients with poor clinical
outcomes (early recurrent stroke, stroke disability and
all-cause death) and those without poor clinical out-
comes at 3 months after minor stroke were tested for
continuous variables with normal distribution using
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one-way analysis of variance and continuous variables
with skewed distribution using Kruskal-Wallis test. The χ2
or Fisher exact test was used for categorical variables.
We analyzed the association between the clinical out-
comes including early recurrent stroke, stroke disability
and all-cause death and relevant covariates with logistic
regression analysis adjusting age, gender, hypertension,
diabetes mellitus, dyslipidemia, atrial fibrillation, coron-
ary heart disease, previous stroke, current or previous
smoking, moderate or heavy alcohol, BMI at admission,
and admission within 24 h or not after stroke onset.
We have determined that two-tailed p values less than
0.05 was statistically significant. All statistical analyses




Of the 22,216 patients enrolled in the CNSR, 18,580 pa-
tients had complete baseline information and agreed to
participate in the 90-day follow-up. Among them, 855 pa-
tients were excluded due to loss to follow-up at 3 months.
After excluding 6891 patients with an initial NIHSS ≥ 4, a
total of 4669 patients with minor stroke (the initial
NIHSS < 4) were remained finally (Fig. 1).
Univariate analysis of patients with or without recurrent
stroke, stroke disability and all-cause death at 3 months
after minor stroke
Of 4669 patients with a minor stroke during 90-day
follow-up, 459 (9.8 %) patients experienced recurrent
stroke, 679 (14.5 %) had stroke disability and 168 (3.6 %)
died. (Tables 1, 2 and 3) Of 168 patients who died, 77
(45.8 %) died of recurrent stroke. In univariate analysis,
patients with stroke recurrence at 3 months after minor
stroke had a higher rate of hypertension, diabetes mellitus,
dyslipidemia, atrial fibrillation, coronary heart disease, pre-
vious stroke, time from onset to admission < 24 h, neuro-
logical deterioration and large-artery atherosclerosis/
cardioembolism subtype of toast type than those without
recurrence. Patients with recurrence stroke were more
likely to be older and have a higher median NIHSS score
at admission than those without recurrence. There was no
difference between patients with recurrence stroke and
those without recurrence stroke in gender, current or pre-
vious smoking, moderate or heavy alcohol, treated atrial
fibrillation, median BMI at admission and median NIHSS
score at 24 h (Table 1).
Table 2 showed older and female patients were more
likely to be dependency at 3 months after minor stroke
(P < 0.05). Patients with dependency were significantly
more likely to have hypertension, diabetes mellitus, atrial
fibrillation, coronary heart disease , previous stroke, current
or previous smoking, moderate or heavy alcohol, time from
onset to arriving at hospital < 24 h, neurological deterior-
ation and large-artery atherosclerosis/cardioembolism
subtype of toast type, as compared with those without
dependency. Finally, patients with dependency had a
higher median BMI at admission and median NIHSS
score at 24 h than those without recurrence. There
was no statistically significant difference between the pa-
tients with dependency and those without dependency in
Fig. 1 Flow chart showing the patient selection. NIHSS, National Institutes of Health Stroke Scale
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the following factors: dyslipidemia and median NIHSS
score at admission.
Factors associated with all-cause death in patients after
minor stroke are showed in Table 3. In the univariate
analysis, the variables associated with death include age,
atrial fibrillation, coronary heart disease, previous stroke,
median BMI and NIHSS score, neurological deterior-
ation and TOAST subtype (all P value < 0.05).
Predictors of outcomes
Figure 2 showed adjusted odds ratios (OR) and 95 %
confidence internals (CI) of the risk factors for stroke
recurrence, stroke disability and all-caused death at
3 months in patients with the minor stroke using the
multivariable logistic regression analysis. We identified
the hypertension, diabetes mellitus, atrial fibrillation,
coronary heart disease and previous stroke as independ-
ent predictors for recurrent stroke at 3 months after
stroke onset. The independent predictors for the stroke
disability at 3 months were age, diabetes mellitus, atrial
fibrillation, previous stroke and time from onset to ad-
mission < 24 h. Age, atrial fibrillation and coronary heart
disease were independently associated with the all-caused
death at 3 months after stroke onset.
Discussion
In the largest sample of Chinese stroke adults to date,
the present study found that a significant minority of pa-
tients with the minor stroke experienced permanent
neurological deficits or death and the recurrent stroke
during the 3-month follow-up period. Nevertheless, pa-
tients at earlier phase after minor stroke were more
likely to have high risk of stroke recurrence and poor
functional outcome at 3 months after stroke onset.
Our data showed a 3-month recurrence rate of 9.8 %
in patients with a minor stroke. The short-term risk of
stroke recurrence was consistent to about 10 % at
3 months after TIA [10, 11], but lower than the range
between 14 and 18 % found in two previous studies of
patients with a minor stroke [7, 21]. The early risk of
sequent stroke is commonly underestimated with the
reason that patients were usually enrolled several days
after a minor stroke and any patient who had a major
stroke before the recruitment was not included. We also
Table 1 Univariate analysis of patients with or without stroke recurrence at 3 months after minor stroke
Variables Overall Recurrence No recurrence P value
Sample size, n (%) 4669 459 (9.8) 4210 (90.2)
Age, median (IQR), year 65 (55–74) 67 (57–76) 65 (55–73) <0.001
Female, n (%) 1656 (35.5) 159 (34.6) 1497 (35.6) 0.70
Vascular risk factors
Hypertension, n (%) 3438 (73.6) 365 (79.5) 3073 (73.0) 0.003
Diabetes mellitus, n (%) 1274 (27.3) 148 (32.2) 1126 (26.8) 0.01
Dyslipidemia, n (%) 550 (11.8) 68 (14.8) 482 (11.4) 0.03
Atrial fibrillation, n (%) 270 (5.8) 53 (11.6) 217 (5.2) <0.001
Treated atrial fibrillation, n (%) 29 (10.7) 4 (7.5) 25 (11.5) 0.55
Coronary heart disease, n (%) 600 (12.8) 90 (19.6) 510 (12.1) <0.001
Previous stroke, n (%) 1451 (31.1) 196 (42.7) 1255 (29.8) <0.001
Current or previous smoking, n (%) 1872 (40.1) 178 (38.8) 1694 (40.2) 0.54
Moderate or heavy alcohol, n (%) 470 (10.1) 47 (10.2) 423 (10.0) 0.90
BMI at admission, median (IQR), kg/m2 24.22 (22.3–26.3) 24.22 (22.4–26.6) 24.22 (22.3–26.3) 0.41
NIHSS score, median (IQR)
At admission 2 (1–3) 1 (0–2) 2 (1–3) 0.001
At 24 h 2 (1–3) 2 (1–3) 2 (1–3) 0.74
Time from onset to admission <24 h, n (%) 2472 (52.9) 263 (57.3) 2209 (52.5) 0.049
Neurological deterioration, n (%) 166 (3.6) 31 (6.8) 135 (3.2) <0.001
TOAST subtype, n (%) <0.001
Large-artery atherosclerosis 1951 (41.8) 208 (45.3) 1743 (41.4)
Small-artery occlusion 1066 (22.8) 84 (18.3) 982 (23.3)
Cardioembolism 131 (2.8) 28 (6.1) 103 (2.4)
Other 176 (3.8) 13 (2.8) 163 (3.9)
IQR interquartile range, NIHSS National Institutes of Health Stroke Scale, BMI body mass index, TOAST Trial of Org 10172 in Acute Stroke Treatment
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detected that hypertension, diabetes mellitus and previ-
ous stroke were predictors of early recurrent stroke, as
was suggested in previous studies [10, 11]. Atrial fibrilla-
tion was independently associated with the risk of early
recurrent stroke, which was not confirmed in population
from western countries [11, 21]. The possible explan-
ation is that in clinical practice of China, unlike North
America and Europe, only 14.3 % stroke patients with
atrial fibrillation receive oral anticoagulation in real clin-
ical practice [22]. Of those patients who developed re-
current stroke in our study, 7.5 % patients with atrial
fibrillation received anticoagulation, which was lower
than the early study. Previous studies had reported that
coronary artery disease was strongly associated with
stroke [23, 24]. Carotid atherosclerosis and stroke of ca-
rotid origin are coronary artery disease risk equivalents
[25], thus coronary artery disease and cerebrovascular
diseases are highly correlated. Our present study found
that coronary artery disease was significantly associated
with the risk of stroke recurrence at 3 months after
adjusting other risk factors, so coronary artery disease
can be regarded as an independent risk factor. The
impact of time after a minor stroke for stroke recurrence
was also dissected out in multivariate model analysis. It
presented that the patients at the earlier phase of minor
stroke were more likely to experience subsequent stroke
(OR 1.22; 95 % CI, 0.99-1.51; p = 0.06).
The clinical functional outcomes of patients with
minor stroke is not invariably benign. The rate of pa-
tients with stroke disability at 3 months in this study
was up to 14.5 %. The multivariable-adjusted analysis re-
vealed that patients at earlier phase of minor stroke
(≤24 h) were about 1.5 times more likely to have a stroke
disability at 3 months, and tended to have all-cause
death at 3 months. The reason was unknown, but it was
reported in a previous study [26] that patients with more
severe stroke immediately contacted emergency services
after stroke onset to avoid disability and death. There-
fore, it’s likely that the time from onset to admission was
a proxy for stroke severity even in minor strokes.
The study had some limitations. First, the participating
hospitals were selected by convenience in nature. The
majority of hospitals selected were tertiary hospitals that
may not represent the status quo of stroke in rural and
Table 2 Univariate analysis of patients with or without stroke disability at 3 months after minor stroke
Variables Overall Disability No disability P value
Sample size, n (%) 4669 679 (14.5) 3990 (85.5)
Age, median (IQR), year 65 (55–74) 72 (62–78) 64 (55–72) <0.001
Female, n (%) 1656 (35.5) 281 (41.4) 1375 (34.5) <0.001
Vascular risk factors
Hypertension, n (%) 3438 (73.6) 527 (77.6) 2911 (73.0) 0.01
Diabetes mellitus, n (%) 1274 (27.3) 251 (37.0) 1023 (25.6) <0.001
Dyslipidemia, n (%) 550 (11.8) 79 (11.6) 471 (11.8) 0.90
Atrial fibrillation, n (%) 270 (5.8) 75 (11.0) 195 (4.9) <0.001
Coronary heart disease, n (%) 600 (12.8) 124 (18.3) 476 (11.9) <0.001
Previous stroke, n (%) 1451 (31.1) 273 (40.2) 1178 (29.5) <0.001
Current or previous smoking, n (%) 1872 (40.1) 229 (33.7) 1643 (41.2) <0.001
Moderate or heavy alcohol, n (%) 470 (10.1) 39 (5.7) 431 (10.8) <0.001
BMI at admission, median (IQR), kg/m2 24.22 (22.3–26.3) 24.03 (22.0–26.0) 24.22 (22.5–26.4) 0.03
NIHSS score, median (IQR)
At admission 2 (1–3) 2 (0–3) 2 (1–3) 0.06
At 24 h 2 (1–3) 3 (2–3) 2 (1–3) <0.001
Time from onset to admission <24 h, n (%) 2472 (52.9) 1641 (54.5) 831 (50.2) 0.005
Neurological deterioration, n (%) 166 (3.6) 270 (39.8) 1927 (48.3) <0.001
TOAST subtype, n (%) <0.001
Large-artery atherosclerosis 1951 (41.8) 303 (44.6) 1648 (41.3)
Small-artery occlusion 1066 (22.8) 94 (13.8) 972 (24.4)
Cardioembolism 131 (2.8) 44 (6.5) 87 (2.2)
Other 176 (3.8) 21 (3.1) 155 (3.9)
Stroke disability was defined as modified Rankin Scale >2; IQR interquartile range, BMI body mass index, NIHSS National Institutes of Health Stroke Scale, TOAST
Trial of Org 10172 in Acute Stroke Treatment
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Table 3 Univariate analysis of patients with or without all-cause death at 3 months after minor stroke
Variables Overall Death No death P value
Sample size, n (%) 4669 168 (3.6) 4501 (96.4)
Age, median (IQR), year 65 (55–74) 72 (60–77) 65 (55–73) <0.001
Female, n (%) 1656 (35.5) 70 (41.7) 1586 (35.2) 0.87
Vascular risk factors
Hypertension, n (%) 3438 (73.6) 122 (72.6) 3316 (73.7) 0.76
Diabetes mellitus, n (%) 1274 (27.3) 46 (27.4) 1228 (27.3) 0.98
Dyslipidemia, n (%) 550 (11.8) 21 (12.5) 529 (11.8) 0.77
Atrial fibrillation, n (%) 270 (5.8) 25 (14.9) 245 (5.4) <0.001
Coronary heart disease, n (%) 600 (12.9) 40 (23.8) 560 (12.4) <0.001
Previous stroke, n (%) 1451 (31.1) 68 (40.5) 1383 (30.7) 0.007
Current or previous smoking, n (%) 1872 (40.1) 62 (36.9) 1810 (40.2) 0.39
Moderate or heavy alcohol, n (%) 470 (10.1) 11 (6.6) 459 (10.2) 0.12
BMI at admission, median (IQR), kg/m2 24.22 (22.3–26.3) 23.61 (21.7–26.0) 24.22 (22.4–26.3) <0.001
NIHSS score, median (IQR)
At admission 2 (1–3) 1 (0–2) 2 (1–3) <0.001
At 24 h 2 (1–3) 2 (1–3) 2 (1–3) 0.006
Time from onset to admission <24 h, n (%) 2472 (52.9) 97 (57.7) 2375 (52.8) 0.20
Neurological deterioration, n (%) 166 (3.6) 19 (11.3) 147 (3.3) <0.001
TOAST subtype, n (%) <0.001
Large-artery atherosclerosis 1951 (41.8) 66 (39.3) 1855 (41.9)
Small-artery occlusion 1066 (22.8) 19 (11.3) 1047 (23.3)
Cardioembolism 131 (2.8) 15 (8.9) 116 (2.6)
Other 176 (3.8) 5 (3.0) 171 (3.8)
IQR interquartile range, BMI body mass index, NIHSS National Institutes of Health Stroke Scale, TOAST Trial of Org 10172 in Acute Stroke Treatment
Fig. 2 The adjusted ORs for stroke recurrence, disability and death at 3 months after stroke onset. Stroke disability was defined as modified
Rankin Scale > =3.OR denotes Odds Ratio; CI, Confidence Internal; BMI, Body Mass Index. Adjusted for age, gender, hypertension, diabetes
mellitus, dyslipidemia, atrial fibrillation, coronary heart disease, previous stroke, current or previous smoking, moderate or heavy alcohol, BMI at
admission, and admission within 24 h
Wu et al. BMC Neurology  (2015) 15:253 Page 6 of 8
smaller community hospitals. Second, unavoidable de-
lays before the inclusion of patients in the study led to
the underestimation of the recurrent stroke risk and
poor functional outcomes. The reason was that a portion
of patients with minor stroke prior to study enrollment
were not categorized into the group of minor stroke due
to recurrent stroke or worsening of their presenting
events. Third, it would be helpful if the abnormality on the
imaging metric could be taken into as part of multivariate
analysis for neurological deterioration. However, the de-
tailed information about imaging was unavailable and the
analysis couldn’t be performed. Furthermore, as we mainly
focus on the impact of risk factors before admission on
outcomes, the other potentially significant factors including
treatments and therapies variables during hospitalization
and at discharge were not included in the analysis.
Conclusions
Our study indicated the short-term risk of early recur-
rent stroke and poor functional outcome in Chinese pa-
tients with a minor stroke was substantial. Therefore,
patients with a minor stroke should be given expeditious
assessment and urgent aggressive intervention.
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